Form 4: eHealth Director A. John Hass Receives Annual RSU Award

eHealth, Inc. Director A. John Hass was granted 34,574 Restricted Stock Units as part of his annual compensation, vesting quarterly from June 17, 2025.

Summary

• A. John Hass, a Director of eHealth, Inc. (EHTH), was awarded 34,574 Restricted Stock Units (RSUs) on June 17, 2025.
• This award is part of the annual compensation for non-employee directors of eHealth.
• Each RSU represents a contingent right to receive one share of eHealth's common stock upon vesting.
• The RSUs are scheduled to vest in four equal quarterly installments, commencing on June 17, 2025.
• Full vesting can also occur immediately prior to the Issuer's next annual stockholder meeting or upon a Change in Control, provided the director maintains their service provider status.
• Following this transaction, A. John Hass beneficially owns a total of 121,893 shares of eHealth common stock.
• A Power of Attorney was executed by A. John Hass on June 19, 2025, authorizing specific individuals to complete and file Section 16 forms (Forms 3, 4, and 5) on his behalf.

Sentiment

Score: 7

Explanation: The filing indicates a routine equity award to a director, which is a positive for aligning management interests with shareholders and reflects standard corporate governance practices. There are no negative implications.

Positives

• The grant of RSUs to a director aligns their financial interests with those of shareholders, as the value of the award is directly tied to the company's stock performance.
• This transaction represents a standard component of non-employee director compensation, indicating stable and routine corporate governance practices.

Risks

• The ultimate value of the Restricted Stock Units is subject to the future market performance of eHealth's common stock.
• Vesting of the RSUs is contingent on the director's continued service to the company; unvested units may be forfeited if service ceases prematurely.

Future Outlook

The awarded Restricted Stock Units are scheduled to vest in four equal quarterly installments starting June 17, 2025. Additionally, there are provisions for accelerated vesting immediately prior to the Issuer's next annual stockholder meeting or upon a Change in Control, contingent on the director's continued service.

Management Comments

• "The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Corporation assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act."

Industry Context

The granting of Restricted Stock Units (RSUs) is a common and widely accepted practice for compensating non-employee directors in publicly traded companies, particularly within the healthcare technology and insurance brokerage sectors like eHealth. This method is designed to align director incentives with long-term shareholder value creation.

Comparison to Industry Standards

• The use of RSUs for non-employee director compensation is a standard practice across many industries, including technology and healthcare, aligning with corporate governance best practices.
• Companies operating in related healthcare and insurance sectors, such as UnitedHealth Group (UNH) or CVS Health (CVS), commonly utilize equity awards, including RSUs, as part of their director compensation packages to foster long-term commitment and align interests.
• The specified vesting schedule, which includes quarterly installments and accelerated vesting triggers (e.g., annual meeting, change in control), is typical for such awards, providing both retention incentives and liquidity events under specific conditions.

Corporate Governance

Related Party Transactions

• The award of 34,574 Restricted Stock Units to A. John Hass, a non-employee director, constitutes a related party transaction as it is compensation provided by the company to a member of its board.

Stakeholder Impact

• Shareholders: The RSU award aligns the director's financial interests with shareholder value, as the value of the award is directly tied to the company's stock performance. This can incentivize long-term strategic decisions beneficial to shareholders.

Next Steps

• Vesting of the 34,574 RSUs in four equal quarterly installments, commencing June 17, 2025.
• Potential accelerated vesting of RSUs on the day immediately prior to the Issuer's next annual stockholder meeting or if the Issuer is subject to a Change in Control.

Key Dates

Keywords

eHealth Inc., EHTH, SEC Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Award, Insider Transaction, Corporate Governance